- Home
- AISP vs TLSA Comparison
AISP vs TLSA Comparison
Compare AISP & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AISP
- TLSA
- Stock Information
- Founded
- AISP 2006
- TLSA 2013
- Country
- AISP United States
- TLSA United Kingdom
- Employees
- AISP N/A
- TLSA N/A
- Industry
- AISP Blank Checks
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- AISP Finance
- TLSA Health Care
- Exchange
- AISP Nasdaq
- TLSA Nasdaq
- Market Cap
- AISP 166.9M
- TLSA 187.0M
- IPO Year
- AISP N/A
- TLSA 2000
- Fundamental
- Price
- AISP $5.44
- TLSA $1.69
- Analyst Decision
- AISP Strong Buy
- TLSA
- Analyst Count
- AISP 1
- TLSA 0
- Target Price
- AISP $6.00
- TLSA N/A
- AVG Volume (30 Days)
- AISP 697.6K
- TLSA 318.4K
- Earning Date
- AISP 08-05-2025
- TLSA 05-06-2025
- Dividend Yield
- AISP N/A
- TLSA N/A
- EPS Growth
- AISP N/A
- TLSA N/A
- EPS
- AISP N/A
- TLSA N/A
- Revenue
- AISP $13,724,085.00
- TLSA N/A
- Revenue This Year
- AISP $34.52
- TLSA N/A
- Revenue Next Year
- AISP $59.54
- TLSA N/A
- P/E Ratio
- AISP N/A
- TLSA N/A
- Revenue Growth
- AISP N/A
- TLSA N/A
- 52 Week Low
- AISP $1.90
- TLSA $0.63
- 52 Week High
- AISP $7.66
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- AISP 64.20
- TLSA 44.18
- Support Level
- AISP $4.17
- TLSA $1.51
- Resistance Level
- AISP $4.41
- TLSA $1.88
- Average True Range (ATR)
- AISP 0.24
- TLSA 0.16
- MACD
- AISP 0.09
- TLSA -0.01
- Stochastic Oscillator
- AISP 96.95
- TLSA 29.03
About AISP Airship AI Holdings Inc.
Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where need it, using a secure permission-based architecture.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.